Trials / Recruiting
RecruitingNCT06740019
A Phase Ib Study of JMKX000197 Injection in the Treatment of Malignant Pleural Effusion
A Phase Ib, Open Label, Multicenter Clinical Study to Evaluate the Safety, Tolerance, Pharmacokinetics, Pharmacodynamics, and Preliminary Efficacy of JMKX000197 Injection in the Treatment of Malignant Pleural Effusion
- Status
- Recruiting
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 30 (estimated)
- Sponsor
- Jemincare · Industry
- Sex
- All
- Age
- 18 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
A Phase Ib Study to Evaluate the Safety, Tolerance, Pharmacokinetics, Pharmacodynamics, and Preliminary Efficacy of JMKX000197 Injection in the Treatment of Malignant Pleural Effusion
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | JMKX000197 | for pleural perfusion |
| PROCEDURE | Tube thoracostomy drainage | Tube thoracostomy drainage |
Timeline
- Start date
- 2024-12-28
- Primary completion
- 2025-12-31
- Completion
- 2026-11-01
- First posted
- 2024-12-18
- Last updated
- 2025-04-04
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT06740019. Inclusion in this directory is not an endorsement.